Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.

Investigators saw more deaths in patients with severe TR after repeat mitral valve procedures; what to do about it is unclear ...

Safe, effective one-year outcomes in severe tricuspid regurgitation, enhancing symptoms and reducing admissions.

"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

The Evoque transcatheter tricuspid valve replacement (TTVR ... Among study participants with symptomatic, severe tricuspid regurgitation (TR), those randomized to TTVR, in lieu of medical therapy ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid ... composite of all-cause mortality or tricuspid valve surgery, heart failure hospitalizations [HFH], and quality ...